Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Astrocytic glutamate transporters, primarily GLT-1 (EAAT2) and GLAST (EAAT1), are essential for maintaining glutamate homeostasis in the central nervous system. They function as high-affinity sodium-dependent symporters, clearing excess glutamate from the synaptic cleft to prevent excitotoxicity and support neurotransmitter cycling. Dysfunction of these transporters is implicated in various neurological and psychiatric disorders, making them potential therapeutic targets.
Sodium-dependent glutamate symporter; clears extracellular L-glutamate.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Astrocytic Glutamate Transporter (EAAT (Astrocytic)).